359 related articles for article (PubMed ID: 24416188)
1. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice.
Karaca G; Swiderska-Syn M; Xie G; Syn WK; Krüger L; Machado MV; Garman K; Choi SS; Michelotti GA; Burkly LC; Ochoa B; Diehl AM
PLoS One; 2014; 9(1):e83987. PubMed ID: 24416188
[TBL] [Abstract][Full Text] [Related]
2. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation.
Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC
J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336
[TBL] [Abstract][Full Text] [Related]
3. TWEAK induces liver progenitor cell proliferation.
Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
[TBL] [Abstract][Full Text] [Related]
4. TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice.
Son A; Oshio T; Kawamura YI; Hagiwara T; Yamazaki M; Inagaki-Ohara K; Okada T; Wu P; Iseki M; Takaki S; Burkly LC; Dohi T
Mucosal Immunol; 2013 Nov; 6(6):1131-42. PubMed ID: 23462911
[TBL] [Abstract][Full Text] [Related]
5. Role of Fn14 in acute alcoholic steatohepatitis in mice.
Karaca G; Xie G; Moylan C; Swiderska-Syn M; Guy CD; Krüger L; Machado MV; Choi SS; Michelotti GA; Burkly LC; Diehl AM
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G325-34. PubMed ID: 25524063
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells.
Tirnitz-Parker JE; Viebahn CS; Jakubowski A; Klopcic BR; Olynyk JK; Yeoh GC; Knight B
Hepatology; 2010 Jul; 52(1):291-302. PubMed ID: 20578156
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.
Tarín C; Fernández-Laso V; Sastre C; Madrigal-Matute J; Gómez M; Zaragoza C; Egido J; Burkly LC; Martín-Ventura JL; Blanco-Colio LM
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092786
[TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
[TBL] [Abstract][Full Text] [Related]
10. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
12. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
Haile WB; Echeverry R; Wu J; Yepes M
J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
[TBL] [Abstract][Full Text] [Related]
13. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
Echeverry R; Wu F; Haile WB; Wu J; Yepes M
J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
[TBL] [Abstract][Full Text] [Related]
14. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration.
Girgenrath M; Weng S; Kostek CA; Browning B; Wang M; Brown SA; Winkles JA; Michaelson JS; Allaire N; Schneider P; Scott ML; Hsu YM; Yagita H; Flavell RA; Miller JB; Burkly LC; Zheng TS
EMBO J; 2006 Dec; 25(24):5826-39. PubMed ID: 17124496
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.
Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C
Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296
[TBL] [Abstract][Full Text] [Related]
16. TNF-like weak inducer of apoptosis (TWEAK) promotes beta cell neogenesis from pancreatic ductal epithelium in adult mice.
Wu F; Guo L; Jakubowski A; Su L; Li WC; Bonner-Weir S; Burkly LC
PLoS One; 2013; 8(8):e72132. PubMed ID: 23991053
[TBL] [Abstract][Full Text] [Related]
17. The TWEAK-Fn14 system as a potential drug target.
Wajant H
Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
[TBL] [Abstract][Full Text] [Related]
18. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
Brown SA; Cheng E; Williams MS; Winkles JA
PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
[TBL] [Abstract][Full Text] [Related]
19. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
20. The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
Mustafa S; Martin HL; Burkly L; Costa A; Martins ML; Schwaninger M; Teismann P
Neuroscience; 2016 Apr; 319():116-22. PubMed ID: 26808775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]